Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2018 | Beyond cancer treatment: nurse specialists in the clinic

Simon Crabb • 29 Nov 2018
ESMO 2018
General Genitourinary Cancer Prostate Cancer

In this video, Simon Crabb, MBBS, MRCP, PhD, of the University of Southampton, Southampton, UK, discusses an initiative taken by his clinic to support patients in not only clinical treatment decision making, but also in broader aspects of care, such as finance and family dealings. Dr Crabb speaks about how involving a prostate cancer nurse specialist has been crucial to achieveing these aims at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.

More from Simon Crabb

Prolonging the effects of CBT on managing hot flushes in men with prostate cancer receiving ADT
0:51
Prolonging the effects of CBT on managing hot flushes in men with prostate cancer receiving ADT
Simon Crabb • 6 Jun 2024
How CBT can help manage hot flushes in men with prostate cancer receiving ADT
0:47
How CBT can help manage hot flushes in men with prostate cancer receiving ADT
Simon Crabb • 6 Jun 2024
GUSTO: use of gene expression patterns to identify unique molecular subtypes in MIBC
1:44
GUSTO: use of gene expression patterns to identify unique molecular subtypes in MIBC
Simon Crabb • 1 Jun 2024
Short-term benefits of self-help CBT for managing hot flushes in prostate cancer patients on ADT
1:13
Short-term benefits of self-help CBT for managing hot flushes in prostate cancer patients on ADT
Simon Crabb • 1 Jun 2024

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals